Grace Therapeutics Inc (GRCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16,862 | 20,005 | 22,133 | 11,055 | 15,155 |
| Marketable Securities | N/A | N/A | N/A | N/A | 15 |
| Receivables | 20 | 20 | 126 | 301 | 415 |
| TOTAL | $17,298 | $20,525 | $22,712 | $11,939 | $16,062 |
| Non-Current Assets | |||||
| PPE Net | 12 | 14 | 15 | 19 | 21 |
| Intangibles | 49,266 | 49,266 | 49,266 | 49,266 | 49,266 |
| TOTAL | $49,278 | $49,280 | $49,281 | $49,285 | $49,287 |
| Total Assets | $66,576 | $69,805 | $71,993 | $61,224 | $65,349 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,245 | 2,315 | 1,930 | 1,971 | 2,674 |
| TOTAL | $1,245 | $2,315 | $1,930 | $1,971 | $2,674 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 201 | 1,628 | 1,141 | 3,781 | 2,603 |
| TOTAL | $2,513 | $3,940 | $3,453 | $7,114 | $6,541 |
| Total Liabilities | $3,758 | $6,255 | $5,383 | $9,085 | $9,215 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,129 | 13,829 | 13,829 | 10,140 | 10,140 |
| Common Shares | 1 | 1 | 1 | 1 | 261,038 |
| Retained earnings | -224,987 | -224,049 | -220,687 | -221,323 | -217,168 |
| Other shareholders' equity | -6,038 | -6,038 | -6,038 | -6,038 | -6,038 |
| TOTAL | $62,818 | $63,550 | $66,610 | $52,139 | $56,134 |
| Total Liabilities And Equity | $66,576 | $69,805 | $71,993 | $61,224 | $65,349 |